Suzann M. Babb

1.2k total citations
27 papers, 921 citations indexed

About

Suzann M. Babb is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Suzann M. Babb has authored 27 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Suzann M. Babb's work include Schizophrenia research and treatment (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Advanced MRI Techniques and Applications (3 papers). Suzann M. Babb is often cited by papers focused on Schizophrenia research and treatment (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Advanced MRI Techniques and Applications (3 papers). Suzann M. Babb collaborates with scholars based in United States, Israel and Japan. Suzann M. Babb's co-authors include Bruce M. Cohen, Perry F. Renshaw, Deborah Yurgelun‐Todd, Andrew L. Stoll, B M Cohen, Gary J. Muehlbauer, Staci A. Gruber, Constance M. Moore, Rosemond A. Villafuerte and Richard J. Wurtman and has published in prestigious journals such as Biological Psychiatry, Brain Research and Magnetic Resonance in Medicine.

In The Last Decade

Suzann M. Babb

26 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzann M. Babb United States 16 250 249 219 160 150 27 921
Shoko Nozaki Japan 15 156 0.6× 202 0.8× 226 1.0× 164 1.0× 105 0.7× 29 900
David Weinzimmer United States 19 124 0.5× 330 1.3× 384 1.8× 151 0.9× 127 0.8× 30 885
Roni Dhaher United States 11 191 0.8× 178 0.7× 320 1.5× 101 0.6× 142 0.9× 16 641
Rosemond A. Villafuerte United States 14 151 0.6× 94 0.4× 165 0.8× 158 1.0× 145 1.0× 20 608
Lisa Muench United States 16 154 0.6× 291 1.2× 363 1.7× 87 0.5× 320 2.1× 20 1.2k
Lars E. Couture United States 9 169 0.7× 268 1.1× 127 0.6× 208 1.3× 260 1.7× 10 929
William G. Honer Canada 10 146 0.6× 240 1.0× 327 1.5× 95 0.6× 146 1.0× 15 894
Pauline Carter United States 17 197 0.8× 316 1.3× 473 2.2× 112 0.7× 332 2.2× 20 1.2k
Kayo Onoe Japan 14 241 1.0× 131 0.5× 159 0.7× 67 0.4× 156 1.0× 27 778
Martin Schain Sweden 19 179 0.7× 281 1.1× 229 1.0× 205 1.3× 134 0.9× 43 1.2k

Countries citing papers authored by Suzann M. Babb

Since Specialization
Citations

This map shows the geographic impact of Suzann M. Babb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzann M. Babb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzann M. Babb more than expected).

Fields of papers citing papers by Suzann M. Babb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzann M. Babb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzann M. Babb. The network helps show where Suzann M. Babb may publish in the future.

Co-authorship network of co-authors of Suzann M. Babb

This figure shows the co-authorship network connecting the top 25 collaborators of Suzann M. Babb. A scholar is included among the top collaborators of Suzann M. Babb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzann M. Babb. Suzann M. Babb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Bruce M., Döst Öngür, Suzann M. Babb, & Peter Q. Harris. (2022). Diagnostic terms psychiatrists prefer to use for common psychotic and personality disorders. Journal of Psychiatric Research. 155. 226–231. 2 indexed citations
2.
Cohen, Bruce M., Döst Öngür, & Suzann M. Babb. (2021). Alternative Diagnostic Models of the Psychotic Disorders: Evidence-Based Choices. Psychotherapy and Psychosomatics. 90(6). 373–385. 11 indexed citations
3.
McPhie, Donna L., Ralda Nehme, Caitlin Ravichandran, et al.. (2018). Oligodendrocyte differentiation of induced pluripotent stem cells derived from subjects with schizophrenias implicate abnormalities in development. Translational Psychiatry. 8(1). 230–230. 43 indexed citations
4.
Hao, Limin, Oshrit Ben‐David, Suzann M. Babb, et al.. (2016). Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans. Neuropsychopharmacology. 42(4). 951–962. 8 indexed citations
5.
Cohen, Bruce M., et al.. (2016). Acute and chronic effects of clozapine on cholinergic transmission in cultured mouse superior cervical ganglion neurons. Journal of Neurogenetics. 30(3-4). 297–305. 3 indexed citations
6.
Murphy, Beth L., Suzann M. Babb, Caitlin Ravichandran, & Bruce M. Cohen. (2014). Oral SAMe in Persistent Treatment-Refractory Bipolar Depression. Journal of Clinical Psychopharmacology. 34(3). 413–416. 20 indexed citations
7.
Murphy, Beth L., Andrew L. Stoll, Peter Q. Harris, et al.. (2012). Omega-3 Fatty Acid Treatment, With or Without Cytidine, Fails to Show Therapeutic Properties in Bipolar Disorder. Journal of Clinical Psychopharmacology. 32(5). 699–703. 36 indexed citations
8.
Babb, Suzann M., Yong Ke, Nicholas Lange, et al.. (2003). Oral choline increases choline metabolites in human brain. Psychiatry Research Neuroimaging. 130(1). 1–9. 37 indexed citations
9.
Babb, Suzann M. & Gary J. Muehlbauer. (2003). Genetic and morphological characterization of the barley uniculm2 (cul2) mutant. Theoretical and Applied Genetics. 106(5). 846–857. 54 indexed citations
10.
Babb, Suzann M., Lawrence L. Wald, B.M. Cohen, et al.. (2002). Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology. 161(3). 248–254. 45 indexed citations
11.
Christensen, James, Deborah Yurgelun‐Todd, Suzann M. Babb, et al.. (1999). Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy. Brain Research. 834(1-2). 1–5. 19 indexed citations
12.
Christensen, James, Suzann M. Babb, Bruce M. Cohen, & Perry F. Renshaw. (1998). Quantitation of dexfenflurainine/d‐norfenfluramine concentration in primate brain using 19F NMR spectroscopy. Magnetic Resonance in Medicine. 39(1). 149–154. 13 indexed citations
13.
Kaufman, Marc J., Jonathan Worth, Suzann M. Babb, et al.. (1997). Elevated frontal lobe cytosolic choline levels in minimal or mild AIDS dementia complex patients: A proton magnetic resonance spectroscopy study. Biological Psychiatry. 41(4). 500–502. 10 indexed citations
14.
Renshaw, Perry F., Beny Lafer, Suzann M. Babb, et al.. (1997). Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry. 41(8). 837–843. 92 indexed citations
15.
16.
Ennulat, David J., Suzann M. Babb, & Bruce M. Cohen. (1994). Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine. Molecular Brain Research. 26(1-2). 106–112. 54 indexed citations
17.
Babb, Suzann M., et al.. (1992). Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Biological Psychiatry. 32(9). 817–824. 65 indexed citations
18.
Campbell, Alexander, et al.. (1989). Persistence of antipsychotic drug effects and tissue levels. Schizophrenia Research. 2(1-2). 198–198. 4 indexed citations
19.
Cohen, Bruce M., Giorgio Stramentinoli, Ana Luisa Sosa, Suzann M. Babb, & V.R. Olgiati. (1989). Effects of the novel antidepressant S-adenosyl-methionine on α1- and β-adrenoceptors in rat brain. European Journal of Pharmacology. 170(3). 201–207. 14 indexed citations
20.
Svendsen, Clive N., Mark Froimowitz, Alexander Campbell, et al.. (1988). Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D1 and D2 receptors in rat brain. Neuropharmacology. 27(11). 1117–1124. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoko Nozaki Breakdown of academic impact, for papers by David Weinzimmer Breakdown of academic impact, for papers by Roni Dhaher Breakdown of academic impact, for papers by Rosemond A. Villafuerte Breakdown of academic impact, for papers by Lisa Muench Breakdown of academic impact, for papers by Lars E. Couture Breakdown of academic impact, for papers by William G. Honer Breakdown of academic impact, for papers by Pauline Carter Breakdown of academic impact, for papers by Kayo Onoe Breakdown of academic impact, for papers by Martin Schain
Rankless by CCL
2026